Ajinomoto Bio-Pharma Services CEO and Key Executive Team

• Mark Cassidy

  CEO & President, Ajinomoto Bio-Pharma Services Europe
• Daigaku Hideura

  CEO of GeneDesign Inc., Ajinomoto Bio-Pharma Services Osaka
• Bert Barbosa

  President & COO, Ajinomoto Bio-Pharma Services United States
• Satoshi Katayama

  VP of Business Transformation, Ajinomoto Bio-Pharma Services United States
• Yasuyuki Otake

  Corporate Executive, General Manager, Bio-Pharma Services Dept.
• Tatsuya Okuzumi

  General Manager, Strategy and Planning Group, Bio-Pharma Services Dept
• Hiroki Inoue

  General Manager, Japan Business Development Group, Bio-Pharma Services Dept
• Erik Riley

  Sr. Vice President, Corporate Planning
• Yasuyuki Otake

  Corporate Executive, General Manager, Bio-Pharma Services Dept.
• Lee Williams

  Vice President, Corporate Engineering
• Paul Ruther

  Vice President, Drug Product Manufacturing
• Betty Wu

  Sr. Director, Project Management
• Kristina Utne

  Sr. Director, Human Resources
• Jennifer Etchison

  Sr. Director, Business Development
• Brian Blagg

  Executive Vice President, Operations
• Jennifer Vavala

  Sr. Director, Quality Assurance
• Patrick De Craene

  Vice President of Finance, Administration & Legal, Europe
• Bruno Flour

  Vice President of Business Systems, IT and Operational Excellence, Europe
• Wouter Biesemans

  Vice President of Compliance
• Eric De Vos

  Vice President of Global Innovation and Director of R&D, Europe
• KVV Raju

  Vice President and Head of Indian Operations

Source: ajibio-pharma.com